Join the 'Metoclopramide' group to help and get support from people like you. How it works
Metoclopramide Blog
| Tweet |
Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey
Posted 11 days ago by Drugs.com
WEDNESDAY, May 16 – Many primary care doctors don't know the long-term side effects of the chemotherapy treatments that cancer survivors under their care may have been given, a new survey found. On the other hand, most oncologists – though not all – are familiar with the side effects of four common treatments used to treat breast and colon cancer, according to the results of the survey being presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. "While oncologists commonly identify the main late effects of four common cancer drugs, primary care providers did not," study author Dr. Larissa Nekhlyudov said during a Wednesday news conference. "This is not surprising in that primary care providers have different training and exposure to chemotherapy drugs," she noted. "However, these findings emphasize that in the transition of patients ... Read more
Related support groups: Cancer, Zyprexa, Reglan, Olanzapine, Nausea/Vomiting -- Chemotherapy Induced, Metoclopramide, Zyprexa Zydis, Cytoxan, Adriamycin, Oxaliplatin, Cyclophosphamide, Taxol, Paclitaxel, Doxorubicin, Zyprexa Intramuscular
Salix Receives FDA Marketing Approval for Metozolv ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Posted 2 Dec 2009 by Drugs.com
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for Metozolv ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. Metozolv ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short-term therapy (4-12 weeks) for adults with symptomatic documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy1. "Metozolv ODT is the first available treatment for both diabetic gastroparesis and symptomatic documented GERD that offers physicians and patients the similar safety and efficacy of metoclopramide with the added convenience of an orally disintegrating tablet formulation," said Ronnie Fass, MD, FACP, FACG and Professor of Internal Medicine at the University of ... Read more
Related support groups: Gastroparesis, Metoclopramide
Ask a Question
Further Information
Related Condition Support Groups
Nausea/Vomiting, Gastroparesis, Migraine, GERD, Nausea/Vomiting -- Postoperative, Nausea/Vomiting -- Chemotherapy Induced, Lactation Augmentation, Small Intestine Intubation, Radiographic Exam